Clinical Trial Update: Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for FND (fludarabine, mitoxantrone, dexamethasone) plus rituximab in lymphoma patients; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Drugs mentioned

• FND (fludarabine, mitoxantrone, dexamethasone)
• Rituximab (rituximab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lymphoma | Phase 3 | Status: COMPLETED | Results posted: 2020-11-16